EE41 UTILIZATION OF TARLATAMAB AND ASSOCIATED HEALTHCARE RESOURCE USE, COSTS, AND ADVERSE EVENTS: A RETROSPECTIVE COHORT STUDY USING A LARGE U.S. HOSPITAL DATABASE

Value in Health 2026

View at publisher

Authors: Chendi Cui, Laura Curry, Ning An Rosenthal

DOI: 10.1016/j.jval.2026.03.337

Cited by: 1

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Medical Coding and Health Information Medication Adherence and Compliance